Patents by Inventor Vijay Pandurang Karche

Vijay Pandurang Karche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oxazoline and isoxazoline derivatives as CRAC modulators
    Patent number: 10292981
    Abstract: The present invention relates to compounds of Formula (I), along with processes for their preparation that are useful for treating, preventing and/or managing the diseases, disorders, syndromes or conditions associated with the modulation of CRAC. The invention further relates to methods of treating, preventing managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of CRAC of Formula (I).
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: May 21, 2019
    Assignee: LUPIN LIMITED
    Inventors: Nageswara Rao Irlapati, Gokul Keruji Deshmukh, Vijay Pandurang Karche, Santosh Madhukar Jachak, Neelima Sinha, Venkata P. Palle, Rajender Kumar Kamboj
  • OXAZOLINE AND ISOXAZOLINE DERIVATIVES AS CRAC MODULATORS
    Publication number: 20170304299
    Abstract: The present invention relates to compounds of Formula (I) along with processes for their preparation that are useful for treating, preventing and/or managing the diseases, disorders, syndromes or conditions associated with the modulation of CRAC. The invention further relates to methods of treating, preventing managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of CRAC of Formula (I).
    Type: Application
    Filed: July 6, 2017
    Publication date: October 26, 2017
    Inventors: Nageswara Rao IRLAPATI, Gokul Keruji DESHMUKH, Vijay Pandurang KARCHE, Santosh Madhukar JACHAK, Neelima SINHA, Venkata P. PALLE, Rajender Kumar KAMBOJ
  • Chromane and chromene derivatives and their use as CRAC modulators
    Patent number: 9790231
    Abstract: The invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine for the treatment of diseases, disorders associated with the modulation of calcium release-activated calcium (CRAC) channel. The invention also relates to pharmaceutical compositions containing such compounds in treating diseases disorders associated with calcium release-activated calcium (CRAC) channel modulators.
    Type: Grant
    Filed: June 23, 2014
    Date of Patent: October 17, 2017
    Assignee: LUPIN LIMITED
    Inventors: Nageswara Rao Irlapati, Kiran Chandrashekhar Kulkarni, Vijay Pandurang Karche, Gokul Keruji Deshmukh, Neelima Sinha, Venkata P. Palle, Rajender Kumar Kamboj
  • Oxazoline and isoxazoline derivatives as CRAC modulators
    Patent number: 9737534
    Abstract: The present invention relates to compounds of Formula (I), along with processes for their preparation that are useful for treating, preventing and/or managing the diseases, disorders, syndromes or conditions associated with the modulation of CRAC. The invention further relates to methods of treating, preventing managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of CRAC of Formula (I).
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: August 22, 2017
    Assignee: LUPIN LIMITED
    Inventors: Nageswara Rao Irlapati, Gokul Keruji Deshmukh, Vijay Pandurang Karche, Santosh Madhukar Jachak, Neelima Sinha, Venkata P. Palle, Rajender Kumar Kamboj
  • SUBSTITUTED PYRIDINE COMPOUNDS AS CRAC MODULATORS
    Publication number: 20160304506
    Abstract: The present invention relates to compounds described herein Formula (I) and pharmaceutical acceptable salts thereof, which modulate the activity of calcium release-activated calcium (CRAC) channel. The invention also describes the compounds of Formula (I) and pharmaceutical compositions containing such compounds thereof for treating, managing, and/or lessening the severity of diseases, disorders, syndromes or conditions associated with the modulation of calcium release-activated calcium (CRAC) channel.
    Type: Application
    Filed: June 20, 2016
    Publication date: October 20, 2016
    Inventors: Nageswara Rao IRLAPATI, Zubair Abdul Wajid SHAIKH, Vijay Pandurang KARCHE, Gokul Keruji DESHMUKH, Neelima SINHA, Venkata P. PALLE, Rajender Kumar KAMBOJ
  • Substituted pyridine compounds as CRAC modulators
    Patent number: 9399638
    Abstract: The present invention relates to compounds described herein Formula (I) and pharmaceutical acceptable salts thereof, which modulate the activity of calcium release-activated calcium (CRAC) channel. The invention also describes the compounds of Formula (I) and pharmaceutical compositions containing such compounds thereof for treating, managing, and/or lessening the severity of diseases, disorders, syndromes or conditions associated with the modulation of calcium release-activated calcium (CRAC) channel.
    Type: Grant
    Filed: May 1, 2013
    Date of Patent: July 26, 2016
    Assignee: LUPIN LIMITED
    Inventors: Nageswara Rao Irlapati, Zubair Abdul Wajid Shaikh, Vijay Pandurang Karche, Gokul Keruji Deshmukh, Neelima Sinha, Venkata P. Palle, Rajender Kumar Kamboj
  • CHROMANE AND CHROMENE DERIVATIVES AND THEIR USE AS CRAC MODULATORS
    Publication number: 20160137659
    Abstract: The invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine for the treatment of diseases, disorders associated with the modulation of calcium release-activated calcium (CRAC) channel. The invention also relates to pharmaceutical compositions containing such compounds in treating diseases disorders associated with calcium release-activated calcium (CRAC) channel modulators.
    Type: Application
    Filed: June 23, 2014
    Publication date: May 19, 2016
    Inventors: Nageswara Rao IRLAPATI, Kiran Chandrashekhar KULKARNI, Vijay Pandurang KARCHE, Gokul Keruji DESHMUKH, Neelima SINHA, Venkata P. PALLE, Rajender Kumar KAMBOJ
  • OXAZOLE AND ISOXAZOLE CRAC MODULATORS
    Publication number: 20160022673
    Abstract: The present invention relates to compounds of Formula (I) along with processes for their preparation that are useful for treating, preventing and/or managing the diseases, disorders, syndromes or conditions associated with the modulation of CRAC. The invention further relates to methods of treating, preventing managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of CRAC of Formula (I).
    Type: Application
    Filed: August 31, 2015
    Publication date: January 28, 2016
    Inventors: Nageswara Rao IRLAPATI, Gokul Keruji DESHMUKH, Vijay Pandurang KARCHE, Santosh Madhukar JACHAK, Neelima SINHA, Venkata P. PALLE, Rajender Kumar KAMBOJ
  • Oxazoline and isoxazoline derivatives as CRAC modulators
    Patent number: 9169242
    Abstract: The present invention relates to compounds that are useful for treating, preventing and/or managing the diseases, disorders, syndromes or conditions associated with the modulation of CRAC and to processes for preparing these compounds. The invention further relates to methods of treating, preventing managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of CRAC by these compounds.
    Type: Grant
    Filed: October 31, 2011
    Date of Patent: October 27, 2015
    Assignee: LUPIN LIMITED
    Inventors: Nageswara Rao Irlapati, Gokul Keruji Deshmukh, Vijay Pandurang Karche, Santosh Madhukar Jachak, Neelima Sinha, Venkata P. Palle, Rajender Kumar Kamboj
  • SUBSTITUTED PYRIDINE COMPOUNDS AS CRAC MODULATORS
    Publication number: 20150111900
    Abstract: The present invention relates to compounds described herein Formula (I) and pharmaceutical acceptable salts thereof, which modulate the activity of calcium release-activated calcium (CRAC) channel. The invention also describes the compounds of Formula (I) and pharmaceutical compositions containing such compounds thereof for treating, managing, and/or lessening the severity of diseases, disorders, syndromes or conditions associated with the modulation of calcium release-activated calcium (CRAC) channel.
    Type: Application
    Filed: May 1, 2013
    Publication date: April 23, 2015
    Inventors: Nageswara Rao Irlapati, Zubair Abdul Wajid Shaikh, Vijay Pandurang Karche, Gokul Keruji Deshmukh, Neelima Sinha, Venkata P. Palle, Rajender Kumar Kamboj
  • OXAZOLINE AND ISOXAZOLINE DERIVATIVES AS CRAC MODULATORS
    Publication number: 20130225600
    Abstract: The present invention relates to compounds of Formula (I) along with processes for their preparation that are useful for treating, preventing and/or managing the diseases, disorders, syndromes or conditions associated with the modulation of CRAC. The invention further relates to methods of treating, preventing managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of CRAC of Formula (I).
    Type: Application
    Filed: October 31, 2011
    Publication date: August 29, 2013
    Applicant: LUPIN LIMITED
    Inventors: Nageswara Rao Irlapati, Gokul Keruji Deshmukh, Vijay Pandurang Karche, Santosh Madhukar Jachak, Neelima Sinha, Venkata P. Palle, Rajender Kumar Kamboj